In-111 Pentetreotide

pentetreotide labeled with indium-111

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for In-111 Pentetreotide, covering 2023-04-03 to 2023-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors [Phase 2, Phase 3]